Form 4: Constellation Brands Non-Executive Chair Acquires 1,114 Restricted Stock Units

Sentiment:

Insider Ownership Report


Christopher J. Baldwin, Non-Executive Chair of Constellation Brands, Inc., acquired 1,114 Restricted Stock Units, which are set to vest on July 10, 2026.

Summary

  • Christopher J. Baldwin, the Non-Executive Chair of the Board and a Director at Constellation Brands, Inc. (STZ), acquired 1,114 Restricted Stock Units (RSUs).
  • The transaction date for the acquisition of these RSUs was July 15, 2025.
  • Each Restricted Stock Unit represents a contingent right to receive one share of Class A Common Stock.
  • All 1,114 Restricted Stock Units are scheduled to vest on July 10, 2026, at which point the vested shares will be delivered to Mr. Baldwin.
  • The acquisition price for these Restricted Stock Units was $0, which is typical for equity grants as part of compensation.
  • Following this transaction, Mr. Baldwin directly beneficially owns 1,114 Restricted Stock Units.

Sentiment

Score: 7

Explanation: The acquisition of Restricted Stock Units by a key executive is a positive signal of alignment between management and shareholder interests, though it is a routine compensation event rather than a significant strategic announcement.

Positives

  • The acquisition of Restricted Stock Units by a key executive like the Non-Executive Chair aligns management's long-term interests with those of shareholders.
  • Equity-based compensation is a common practice to incentivize performance and retention of key personnel.

Future Outlook

The vesting schedule for the acquired Restricted Stock Units indicates a future delivery of Class A Common Stock to the reporting person on July 10, 2026, contingent on continued service.

Industry Context

This transaction is a standard form of equity compensation for senior executives and board members in publicly traded companies across various industries, including the beverage alcohol industry where Constellation Brands operates. Such grants are designed to align executive incentives with long-term shareholder value creation.

Comparison to Industry Standards

  • The grant of Restricted Stock Units (RSUs) to a Non-Executive Chair is a common practice in corporate governance across industries, including consumer staples and beverage sectors, aligning executive incentives with long-term shareholder value.
  • Companies like Anheuser-Busch InBev (BUD), Diageo (DEO), and Molson Coors Beverage Company (TAP) frequently utilize similar equity compensation structures for their board members and executives to foster retention and performance.
  • The vesting schedule of approximately one year is within typical industry ranges for RSU grants to non-executive directors, which often vary from immediate vesting to multi-year schedules depending on the company's compensation philosophy and specific role.

Stakeholder Impact

  • Shareholders: The grant of equity aligns the interests of a key board member with shareholders, potentially fostering long-term value creation.

Next Steps

  • Delivery of vested Class A Common Stock to Christopher J. Baldwin on July 10, 2026, upon vesting of the Restricted Stock Units.

Key Dates

DateDescription
07/15/2025Date of earliest transaction: Acquisition of 1,114 Restricted Stock Units by Christopher J. Baldwin.
07/17/2025Date the Form 4 filing was signed.
07/10/2026Vesting date for all 1,114 Restricted Stock Units, at which point vested shares will be delivered.

Keywords

Constellation Brands, STZ, Restricted Stock Units, RSU, Insider Trading, SEC Form 4, Equity Compensation, Christopher J. Baldwin, Director, Non-Executive Chair

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.